Neurotransmitters are regulators for the migration of tumor cells and leukocytes

被引:80
作者
Entschladen, F [1 ]
Lang, K [1 ]
Drell, TL [1 ]
Joseph, J [1 ]
Zaenker, KS [1 ]
机构
[1] Univ Witten Herdecke, Inst Immunol, D-58448 Witten, Germany
关键词
cell migration; neurotransmitter; serpentine receptor;
D O I
10.1007/s00262-002-0300-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Neurotransmitters are signal substances that have traditionally been regarded as mere mediators of signal states between cells in the nervous system. Whereas the mechanisms of this "classic" neurotransmitter regulation are well understood, only recently has new evidence come to light elucidating the modulatory role of neurotransmitters in immune function, and in the regulation of migration of leukocytes and tumor cells. The migration of leukocytes is. among other things, of primary importance for an anti-tumor immune response, whereas the migration of tumor cells is a prerequisite for invasion and the development of metastases. We here clarify and consolidate the latest tumor biological findings on the role of these neurotransmitters, which bind to serpentine receptors, and which are involved in leukocyte migration. tumor growth, invasion and metastasis. This review thus accentuates the complex. interactive involvement of neurotransmitters in the regulation of migration of both leukocytes and tumor cells.
引用
收藏
页码:467 / 482
页数:16
相关论文
共 244 条
  • [1] Transcriptional mechanisms for induction of 5-HT1A receptor mRNA and protein in activated B and T lymphocytes
    Abdouh, M
    Storring, JM
    Riad, M
    Paquette, Y
    Albert, PR
    Drobetsky, E
    Kouassi, E
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (06) : 4382 - 4388
  • [2] Sumatriptan increases the proliferation of peripheral blood mononuclear cells from HIV-infected individuals and healthy blood donors in vitro
    Afzelius, P
    Nielsen, JO
    [J]. APMIS, 2000, 108 (01) : 74 - 78
  • [3] Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma
    Agarwala, SS
    Glaspy, J
    O'Day, SJ
    Mitchell, M
    Gutheil, J
    Whitman, E
    Gonzalez, R
    Hersh, E
    Feun, L
    Belt, R
    Meyskens, F
    Hellstrand, K
    Wood, D
    Kirkwood, JM
    Gehlsen, KR
    Naredi, P
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) : 125 - 133
  • [4] B1 receptors as a new inflammatory target.: Could this B the 1?
    Ahluwalia, A
    Perretti, M
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1999, 20 (03) : 100 - 104
  • [5] CALCITONIN-GENE-RELATED PEPTIDES MODULATE THE ACUTE INFLAMMATORY RESPONSE INDUCED BY INTERLEUKIN-1 IN THE MOUSE
    AHLUWALIA, A
    PERRETTI, M
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 264 (03) : 407 - 415
  • [6] Dopamine β-hydroxylase deficiency impairs cellular immunity
    Alaniz, RC
    Thomas, SA
    Perez-Melgosa, M
    Mueller, K
    Farr, AG
    Palmiter, RD
    Wilson, CB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (05) : 2274 - 2278
  • [7] Somatostatin controls Kaposi's sarcoma tumor growth through inhibition of angiogenesis
    Albini, A
    Florio, T
    Giunciuglio, D
    Masiello, L
    Carlone, S
    Corsaro, A
    Thellung, S
    Cai, T
    Noonan, DM
    Schettini, G
    [J]. FASEB JOURNAL, 1999, 13 (06) : 647 - 655
  • [8] Ali H, 2000, J CARDIOVASC PHARM, V36, pS69
  • [9] Aprikian AG, 1997, INT J CANCER, V72, P498, DOI 10.1002/(SICI)1097-0215(19970729)72:3<498::AID-IJC19>3.3.CO
  • [10] 2-P